|
1
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: Good or bad news from the 2018
global cancer statistics? Cancer Commun (Lond).
39(22)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lucas C, Barnich N and Nguyen HT:
Microbiota, inflammation and colorectal cancer. Int J Mol Sci.
18(1310)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang X and Li T: Development of a 15-gene
signature for predicting prognosis in advanced colorectal cancer.
Bioengineered. 11:165–174. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bian M, Wang X, Sun Y and Liu W: Synthesis
and biological evaluation of gold(III) Schiff base complexes for
the treatment of hepatocellular carcinoma through attenuating TrxR
activity. Eur J Med Chem. 193(112234)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yao J, Duan D, Song ZL, Zhang J and Fang
J: Sanguinarine as a new chemical entity of thioredoxin reductase
inhibitor to elicit oxidative stress and promote tumor cell
apoptosis. Free Radic Biol Med. 20:659–667. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y,
Nakamura H, Yodoi J, Kato K and Noguchi S: High thioredoxin
expression is associated with resistance to docetaxel in primary
breast cancer. Clin Cancer Res. 11:8425–8430. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Peng W, Zhou Z, Zhong Y, Sun Y, Wang Y,
Zhu Z, Jiao W, Bai M, Sun J, Lu J and Yin H: Plasma activity of
thioredoxin reductase as a novel biomarker in gastric cancer. Sci
Rep. 9(19084)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Xu L, Zhao Y, Pan F, Zhu M, Yao L, Liu Y,
Feng J, Xiong J, Chen X, Ren F, et al: Inhibition of the Nrf2-TrxR
axis sensitizes the drug-resistant chronic myelogenous leukemia
cell line K562/G01 to imatinib treatments. Biomed Res Int.
2019(6502793)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhu B, Ren C, Du K, Zhu H, Ai Y, Kang F,
Luo Y, Liu W, Wang L, Xu Y, et al: Olean-28,13b-olide 2 plays a
role in cisplatin-mediated apoptosis and reverses cisplatin
resistance in human lung cancer through multiple signaling
pathways. Biochem Pharmacol. 170(113642)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bian M, Fan R, Zhao S and Liu W: Targeting
the thioredoxin system as a strategy for cancer therapy. J Med
Chem. 62:7309–7321. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang J, Li X, Han X, Liu R and Fang J:
Targeting the thioredoxin system for cancer therapy. Trends
Pharmacol Sci. 38:794–808. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Arnér ES: Targeting the selenoprotein
thioredoxin reductase 1 for anticancer therapy. Adv Cancer Res.
136:139–151. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Scalcon V, Bindoli A and Rigobello MP:
Significance of the mitochondrial thioredoxin reductase in cancer
cells: An update on role, targets and inhibitors. Free Radic Biol
Med. 127:62–79. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Stafford WC, Peng X, Olofsson MH, Zhang X,
Luci DK, Lu L, Cheng Q, Trésaugues L, Dexheimer TS, Coussens NP, et
al: Irreversible inhibition of cytosolic thioredoxin reductase 1 as
a mechanistic basis for anticancer therapy. Sci Transl Med.
10(eaaf7444)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kingston DG: Modern natural products drug
discovery and its relevance to biodiversity conservation. J Nat
Prod. 74:496–511. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mishra BB and Tiwari VK: Natural products:
An evolving role in future drug discovery. Eur J Med Chem.
46:4769–4807. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Stefanon B and Colitti M: Original
research: Hydroxytyrosol, an ingredient of olive oil, reduces
triglyceride accumulation and promotes lipolysis in human primary
visceral adipocytes during differentiation. Exp Biol Med.
241:1796–1802. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Goldstein DS, Jinsmaa Y, Sullivan P,
Holmes C, Kopin IJ and Sharabi Y: 3,4-dihydroxyphenylethanol
(hydroxytyrosol) mitigates the increase in spontaneous oxidation of
dopamine during monoamine oxidase inhibition in PC12 cells.
Neurochem Res. 41:2173–2178. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Persia FA, Mariani ML, Fogal TH and
Penissi AB: Hydroxytyrosol and oleuropein of olive oil inhibit mast
cell degranulation induced by immune and non-immune pathways.
Phytomedicine. 21:1400–1405. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bedoya LM, Beltrán M, Obregón-Calderón P,
García-Pérez J, de la Torre HE, González N, Pérez-Olmeda M, Auñón
D, Capa L, Gómez-Acebo E and Alcamí J: Hydroxytyrosol: A new class
of microbicide displaying broad anti-HIV-1 activity. AIDS.
30:2767–2776. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Walter WM Jr, Fleming HP and Etchells JL:
Preparation of antimicrobial compounds by hydrolysis of oleuropein
from green olives. Appl Microbiol. 26:773–776. 1973.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Medina E, de Castro A, Romero C and Brenes
M: Comparison of the concentrations of phenolic compounds in olive
oils and other plant oils: Correlation with antimicrobial activity.
J Agric Food Chem. 54:4954–4961. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sirianni R, Chimento A, De Luca A,
Casaburi I, Rizza P, Onofrio A, Iacopetta D, Puoci F, Andò S,
Maggiolini M and Pezzi V: Oleuropein and hydroxytyrosol inhibit
MCF-7 breast cancer cell proliferation interfering with ERK1/2
activation. Mol Nutr Food Res. 54:833–840. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chimento A, Casaburi I, Rosano C, Avena P,
De Luca A, Campana C, Martire E, Santolla MF, Maggiolini M, Pezzi V
and Sirianni R: Oleuropein and hydroxytyrosol activate GPER/
GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3
breast cancer cells. Mol Nutr Food Res. 58:478–489. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Luo C, Li Y, Wang H, Cui Y, Feng Z, Li H,
Li Y, Wang Y, Wurtz K, Weber P, et al: Hydroxytyrosol promotes
superoxide production and defects in autophagy leading to
anti-proliferation and apoptosis on human prostate cancer cells.
Curr Cancer Drug Targets. 13:625–639. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sun L, Luo C and Liu J: Hydroxytyrosol
induces apoptosis in human colon cancer cells through ROS
generation. Food Funct. 5:1909–1914. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Toteda G, Lupinacci S, Vizza D, Bonofiglio
R, Perri E, Bonofiglio M, Lofaro D, La Russa A, Leone F, Gigliotti
P, et al: High doses of hydroxytyrosol induce apoptosis in
papillary and follicular thyroid cancer cells. J Endocrinol Invest.
40:153–162. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Terzuoli E, Giachetti A, Ziche M and
Donnini S: Hydroxytyrosol, a product from olive oil, reduces colon
cancer growth by enhancing epidermal growth factor receptor
degradation. Mol Nutr Food Res. 60:519–529. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhao B, Ma Y, Xu Z, Wang J, Wang F, Wang
D, Pan S, Wu Y, Pan H, Xu D, et al: Hydroxytyrosol, a natural
molecule from olive oil, suppresses the growth of human
hepatocellular carcinoma cells via inactivating AKT and nuclear
factor-kappa B pathways. Cancer Lett. 347:79–87. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zubair H, Bhardwaj A, Ahmad A, Srivastava
SK, Khan MA, Patel GK, Singh S and Singh AP: Hydroxytyrosol induces
apoptosis and cell cycle arrest and suppresses multiple oncogenic
signaling pathways in prostate cancer cells. Nutr Cancer.
69:932–942. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang J, Zhang B, Li X, Han X, Liu R and
Fang J: Small molecule inhibitors of mammalian thioredoxin
reductase as potential anticancer agents: An update. Med Res Rev.
39:5–39. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Arnér ES, Sarioglu H, Lottspeich F,
Holmgren A and Böck A: High-level expression in Escherichia coli of
selenocysteine-containing rat thioredoxin reductase utilizing gene
fusions with engineered bacterial-type SECIS elements and
co-expression with the selA, selB and selC genes. J Mol Biol.
292:1003–1016. 1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang L, Duan D, Liu Y, Ge C, Cui X, Sun J
and Fang J: Highly selective off-on fluorescent probe for imaging
thioredoxin reductase in living cells. J Am Chem Soc. 136:226–233.
2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang J, Duan D, Osama A and Fang J:
Natural molecules targeting thioredoxin system and their
therapeutic potential. Antioxid Redox Signal. 34:1083–1107.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang J, Duan D, Song ZL, Liu T, Hou Y and
Fang J: Small molecules regulating reactive oxygen species
homeostasis for cancer therapy. Med Res Rev. 41:342–394.
2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhong L and Holmgren A: Essential role of
selenium in the catalytic activities of mammalian thioredoxin
reductase revealed by characterization of recombinant enzymes with
selenocysteine mutations. J Biol Chem. 275:18121–18128.
2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhong L, Arnér ES and Holmgren A:
Structure and mechanism of mammalian thioredoxin reductase: The
active site is a redox-active selenolthiol/selenenylsulfide formed
from the conserved cysteine-selenocysteine sequence. Proc Natl Acad
Sci U S A. 97:5854–5859. 2000.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cai W, Zhang L, Song Y, Wang B, Zhang B,
Cui X, Hu G, Liu Y, Wu J and Fang J: Small molecule inhibitors of
mammalian thioredoxin reductase. Free Radic Biol Med. 52:257–265.
2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lo YC, Ko TP, Su WC, Su TL and Wang AH:
Terpyridine-platinum(II) complexes are effective inhibitors of
mammalian topoisomerases and human thioredoxin reductase 1. J Inorg
Biochem. 103:1082–1092. 2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ng HL, Ma X, Chew EH and Chui WK: Design,
synthesis, and biological evaluation of coupled bioactive scaffolds
as potential anticancer agents for dual targeting of dihydrofolate
reductase and thioredoxin reductase. J Med Chem. 60:1734–1745.
2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu Y, Duan D, Yao J, Zhang B, Peng S, Ma
H, Song Y and Fang J: Dithiaarsanes induce oxidative
stress-mediated apoptosis in HL-60 cells by selectively targeting
thioredoxin reductase. J Med Chem. 57:5203–5211. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhang B, Duan D, Ge C, Yao J, Liu Y, Li X
and Fang J: Synthesis of xanthohumol analogues and discovery of
potent thioredoxin reductase inhibitor as potential anticancer
agent. J Med Chem. 58:1795–1805. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tuladhar A and Rein KS: Manumycin A is a
potent inhibitor of mammalian thioredoxin reductase-1 (TrxR-1). ACS
Med Chem Lett. 9:318–322. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xie L, Luo Z, Zhao Z and Chen T:
Anticancer and antiangiogenic iron(II) complexes that target
thioredoxin reductase to trigger cancer cell apoptosis. J Med Chem.
60:202–214. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Bertelli M, Kiani AK, Paolacci S, Manara
E, Kurti D, Dhuli K, Bushati V, Miertus J, Pangallo D, Baglivo M,
et al: Hydroxytyrosol: A natural compound with promising
pharmacological activities. J Biotechnol. 309:29–33.
2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Britton J, Davis R and O'Connor KE:
Chemical, physical and biotechnological approaches to the
production of the potent antioxidant hydroxytyrosol. Appl Microbiol
Biotechnol. 103:5957–5974. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Romana-Souza B, Saguie BO, Pereira de
Almeida Nogueira N, Paes M, Dos Santos Valença S, Atella GC and
Monte-Alto-Costa A: Oleic acid and hydroxytyrosol present in olive
oil promote ROS and inflammatory response in normal cultures of
murine dermal fibroblasts through the NF-κB and NRF2 pathways. Food
Res Int. 131(108984)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sun T, Chen Q, Zhu SY, Wu Q, Liao CR, Wang
Z, Wu XH, Wu HT and Chen JT: Hydroxytyrosol promotes autophagy by
regulating SIRT1 against advanced oxidation protein productinduced
NADPH oxidase and inflammatory response. Int J Mol Med.
44:1531–1540. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Avola R, Graziano AC, Pannuzzo G, Bonina F
and Cardile V: Hydroxytyrosol from olive fruits prevents
blue-light-induced damage in human keratinocytes and fibroblasts. J
Cell Physiol. 234:9065–9076. 2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Peng S, Zhang B, Yao J, Duan D and Fang J:
Dual protection of hydroxytyrosol, an olive oil polyphenol, against
oxidative damage in PC12 cells. Food Funct. 6:2091–2100.
2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Long LH, Hoi A and Halliwell B:
Instability of, and generation of hydrogen peroxide by, phenolic
compounds in cell culture media. Arch Biochem Biophys. 501:162–169.
2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Fabiani R, Fuccelli R, Pieravanti F, De
Bartolomeo A and Morozzi G: Production of hydrogen peroxide is
responsible for the induction of apoptosis by hydroxytyrosol on
HL60 cells. Mol Nutr Food Res. 53:887–896. 2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Fabiani R, Sepporta MV, Rosignoli P, De
Bartolomeo A, Crescimanno M and Morozzi G: Anti-proliferative and
pro-apoptotic activities of hydroxytyrosol on different tumour
cells: The role of extracellular production of hydrogen peroxide.
Eur J Nutr. 51:455–464. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Rosignoli P, Fuccelli R, Sepporta MV and
Fabiani R: In vitro chemo-preventive activities of hydroxytyrosol:
The main phenolic compound present in extra-virgin olive oil. Food
Funct. 7:301–307. 2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Fan QZ, Zhou J, Zhu YB, He LJ, Miao DD,
Zhang SP, Liu XP and Zhang C: Design, synthesis, and biological
evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and
thioredoxin reductase (TrxR) dual inhibitor. Bioorg Chem.
105(104401)2020.PubMed/NCBI View Article : Google Scholar
|
